CompletedNCT00060905
Extended-release valproate for mania in adults with bipolarity
About this title
Read the official source — NCT00060905Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Cerritos and 17 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateJanuary 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 370
- Sponsor
- Abbott
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00060905
- Official title
Show the full official title
An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedCerritos · Torrance · Washington D.C.
15 more locations
- Hoffman Estates
- Louisville
- Shreveport
- Rockville
- Belmont
- Baltimore
- Jackson
- Clementon
- Holliswood
- New York
- Cleveland
- Houston
- San Antonio
- Falls Church
- Milwaukee
Questions about this study
Who is behind this study?
The study sponsor is Abbott.
Did this study involve medication?
Yes. The study involved medication, including Divalproex Sodium (Depakote ER).
Who was this study for?
Listed age limits: 18 years to 65 years.
